Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Change in Receivables (2017 - 2022)

Creative Medical Technology Holdings (CELZ) has disclosed Change in Receivables for 6 consecutive years, with -$2485.0 as the latest value for Q1 2022.

  • On a quarterly basis, Change in Receivables changed N/A to -$2485.0 in Q1 2022 year-over-year; TTM through Dec 2022 was -$2485.0, a 200.0% decrease, with the full-year FY2022 number at -$2485.0, down 200.0% from a year prior.
  • Change in Receivables was -$2485.0 for Q1 2022 at Creative Medical Technology Holdings, down from $2485.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $18900.0 in Q4 2019 to a low of -$23500.0 in Q3 2019.
  • A 5-year average of $1107.6 and a median of $1400.0 in 2020 define the central range for Change in Receivables.
  • Biggest YoY gain for Change in Receivables was 529.55% in 2019; the steepest drop was 355.43% in 2019.
  • Creative Medical Technology Holdings' Change in Receivables stood at -$4400.0 in 2018, then soared by 529.55% to $18900.0 in 2019, then tumbled by 92.59% to $1400.0 in 2020, then surged by 77.5% to $2485.0 in 2021, then crashed by 200.0% to -$2485.0 in 2022.
  • Per Business Quant, the three most recent readings for CELZ's Change in Receivables are -$2485.0 (Q1 2022), $2485.0 (Q4 2021), and $1400.0 (Q3 2020).